Cargando…
Estimating the effectiveness of remdesivir on risk of COVID-19 mortality: The role of observational data
Autores principales: | Giacomelli, Andrea, Cozzi-Lepri, Alessandro, Casalini, Giacomo, Oreni, Letizia, Ridolfo, Anna Lisa, Antinori, Spinello |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119862/ https://www.ncbi.nlm.nih.gov/pubmed/35605811 http://dx.doi.org/10.1016/j.phrs.2022.106268 |
Ejemplares similares
-
Remdesivir in moderate to severe COVID-19: A matter of time?
por: Bonazzetti, Cecilia, et al.
Publicado: (2021) -
Trend in the proportion of subjects with SARS-CoV-2 infection without COVID-19 specific symptoms among patients admitted to a COVID-19 referral hospital
por: Giacomelli, Andrea, et al.
Publicado: (2023) -
Evolution of the SARS-CoV-2 epidemic: From genomic surveillance to new health needs
por: Giacomelli, Andrea, et al.
Publicado: (2023) -
Low influenza vaccination coverage among hospitalized COVID-19 patients in Milan: A gap to be urgently filled
por: Ridolfo, Anna Lisa, et al.
Publicado: (2021) -
SARS-CoV-2 viremia and COVID-19 mortality: A prospective observational study
por: Giacomelli, Andrea, et al.
Publicado: (2023)